Pharma Journalist -

T-Cure Bioscience, Inc., a privately held clinical-stage immuno-oncology company developing the next generation of T cell receptor (TCR) therapies for patients with solid tumors, and…
Read More...

Gritstone Oncology, Inc. a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, announced that it is advancing…
Read More...

Cocrystal Pharma, Inc. a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses,…
Read More...

Thermo Fisher Scientific Inc. announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450…
Read More...

Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company and Merus N.V. a clinical-stage oncology company developing multi-specific antibodies, today announced…
Read More...

SMi Reports: The Injectable Drug Delivery Conference returns as a virtual event on 12th and 13th May 2021 Part of Europe’s leading Injectable conference series, we will assess…
Read More...

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune…
Read More...

TenNor Therapeutics (Suzhou) Limited, a clinical-stage biopharmaceutical company dedicated to research and development of differentiated products for the treatment of diseases…
Read More...

Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel Adeno-Associated Virus (AAV) vectorsleveraging Cure Genetics' proprietary VELP platform to develop…
Read More...

Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, and Lonza announced their agreement in support of ARU-1801, Aruvant's one-time…
Read More...